Literature DB >> 22843246

Transient Charles Bonnet syndrome in a patient with reversible cerebral vasoconstriction syndrome.

Yohsuke Yagi, Yukiko Watanabe, Hiroaki Yokote, Takeshi Amino, Tomoyuki Kamata.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843246     DOI: 10.1007/s10072-012-1171-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

Review 1.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

2.  Reversible cerebral vasoconstriction syndromes: analysis of 139 cases.

Authors:  Aneesh B Singhal; Rula A Hajj-Ali; Mehmet A Topcuoglu; Joshua Fok; James Bena; Donsheng Yang; Leonard H Calabrese
Journal:  Arch Neurol       Date:  2011-04-11

Review 3.  Neuroimaging studies in patients with Charles Bonnet Syndrome.

Authors:  Hiroaki Kazui; Ryouhei Ishii; Tetsuhiko Yoshida; Koji Ikezawa; Masahiko Takaya; Hiromasa Tokunaga; Toshihisa Tanaka; Masatoshi Takeda
Journal:  Psychogeriatrics       Date:  2009-06       Impact factor: 2.440

4.  Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome.

Authors:  R J Teunisse; J R Cruysberg; W H Hoefnagels; A L Verbeek; F G Zitman
Journal:  Lancet       Date:  1996-03-23       Impact factor: 79.321

5.  The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen.

Authors:  R J Teunisse; J R Cruysberg; A Verbeek; F G Zitman
Journal:  Br J Psychiatry       Date:  1995-02       Impact factor: 9.319

  5 in total
  1 in total

Review 1.  Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations.

Authors:  T T Winton-Brown; A Ting; R Mocellin; M Walterfang; D Velakoulis; F Gaillard
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.